About OPT Congress: Oligonucleotides, mRNA & Peptide Therapeutics
OPT Congress 2026 is the leading industry event for scientists, directors, and technology providers driving innovation across oligonucleotide, mRNA, and peptide therapeutics. Now in its 11th year, this event provides a unique forum for translating cutting-edge science into transformative medicines, with expanded 2026 programming that includes the brand-new Peptides & Emerging Drug Conjugates conference. This year’s agenda brings together experts from discovery through development, with dedicated content spanning AI-enabled design, extrahepatic delivery, scalable manufacturing, and next-gen modalities including saRNA, circular RNA, and radioligand peptide conjugates.
Across four focused conferences —Oligonucleotide Discovery & Delivery, CMC & Manufacturing, mRNA & Emerging Modalities, and Peptides & Emerging Conjugates—attendees will explore 60+ scientific presentations, collaborative case studies, and real-world implementation strategies. From novel linkers and chemistries to regulatory insights, tech transfer, and delivery breakthroughs, OPT Congress fosters dialogue between pharma, biotech, academia, and technology providers. Join us for two days of actionable insights, short courses, and customizable content designed to support your therapeutic programs from bench to bedside.
Top Reasons to Attend
Be inspired by science-driven plenary sessions
Gain insights from world-renowned academics and industry leaders as they share the latest breakthroughs in oligonucleotide and mRNA discovery, delivery technologies, and CMC and manufacturing strategies driving therapeutic innovation.
Choose from four expertly curated conferences—including new peptide coverage
Tailor your experience across focused tracks covering oligonucleotide discovery and delivery, CMC and manufacturing, mRNA and emerging modalities, and, new for 2026, peptides and novel drug conjugates. With on-demand access included, gain insights across every corner of the field.
Learn from case studies driving real-world impact
Explore how experts are solving challenges in tissue-specific delivery, extrahepatic targeting, oral bioavailability, AI-enabled design, and regulatory compliance. Hear how candidates are moving from discovery through IND and clinical trials.
Stay ahead of emerging scientific and technological trends
Delve into the latest in GalNAc and lipid-based delivery, circular and saRNA platforms, conjugate chemistries, linker design, and AI/ML tools reshaping oligo and peptide-based drug development.
Enhance your expertise with interactive short courses
Join in-depth, hands-on sessions that tackle critical areas including understanding the unique safety and toxicity profiles of nucleic acid therapeutics, and navigating successful regulatory submissions for complex oligonucleotides. These expert-led courses offer practical frameworks for risk assessment, control strategies, and regulatory readiness from early development through registration.
Network with the people who matter
Engage with leading scientists, executive directors, regulatory strategists, formulation experts, and business development leaders in breakout groups, curated networking sessions, and informal meetups.
Discover technologies advancing therapeutic pipelines
Explore the exhibit hall and poster sessions to connect with innovative platform developers, CROs, CDMOs, and analytics providers offering next-gen solutions to accelerate your development timelines.